Published on Tuesday February 02, 2021
Smooth Drug Development January 2021 News Release
We are happy to present our new signed projects:
- Contract for CTA submission of the final report with a new Sponsor.
- Agreement for a bioequivalence study (INN: Dutasteride + Tamsulosin).
Clinical and Scientific Departments News:
- All initiation visits were performed in the phase III Acetylcysteine trial.
- Initiation visits were performed in a III phase trial with Nimesulide, gel.
- Clinical study report in Paracetamol bioequivalence trial was sent to the Sponsor.
- We performed initiation visits in 2 sites in trial with Ethylmethylhydroxypyridine succinate.